GoKawiilCDC sets aside $1.6M for suspended Guinea-Bissau hepatitis B vaccine trial
Rolling Stone reports that CDC director's office staff instructed the agency's budget office in late September to earmark $1.6 million for a vaccine trial in Guinea-Bissau that was suspended in January after being widely criticized as unethical. The trial, which would expose newborns to hepatitis B risk, is to be run by Danish researchers Christine Stabell Benn and Peter Aaby, who are currently under investigation by Danish authorities for alleged scientific misconduct. HHS did not respond to a request for comment.